(E)-2-(2-(furan-2-yl)vinyl)-1H-benzo[d]imidazole

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: (E)-2-(2-(furan-2-yl)vinyl)-1H-benzo[d]imidazole
• 英文别名: 2-[(E)-2-(furan-2-yl)ethenyl]-1H-benzimidazole
• 化学式: C₁₃H₁₀N₂O
• mdl: MFCD01858395
• 分子量: 210.235
• InChiKey: LPLLNBVBHIZVJV-BQYQJAHWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  41.8
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (E)-2-(2-(furan-2-yl)vinyl)-1H-benzo[d]imidazole 以60%的产率得到
  参考文献：
  名称：

  KUZMIERKIEWICZ W., ACTA POL. PHARM., 43,(1986) N 2, 111-115

  摘要：

  DOI：
• 作为产物：
  描述：

  糠醛 在 copper(l) iodide 、 溶剂黄146 、 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 1.5h， 生成 (E)-2-(2-(furan-2-yl)vinyl)-1H-benzo[d]imidazole
  参考文献：
  名称：

  α-Aroylidineketene dithioacetal chemistry: CuI catalyzed synthesis of 2-styryl benzimidazoles enroute to regioselective hydrothiolation

  摘要：

  Reactivity of alpha-aroylidineketene dithioacetals 2 was investigated to synthesize novel 2-styrylbenzimidazole derivatives 4 and their hydrothiolated product 2-(2-(methylthio)-2-arylethyl)-1H-benzoidlimidazoles 5 has been reported. Compounds 4 and 5 were synthesized by cyclocondensation of alpha-aroylidineketene dithioacetals 2 and o-phenylene diamine (OPD) 3 in the presence and absence of copper catalyst respectively. Regioselective one-pot tandem hydrothiolation of olefin functionality in 4 was achieved under AcOH conditions. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2015.06.008

文献信息

• SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
  申请人：Panicker Bijoy

  公开号：US20110237633A1

  公开（公告）日：2011-09-29

  The present invention provides compounds and pharmaceutically acceptable compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which hepatocyte growth factor/scatter factor (HGF/SF) or the activities thereof, or agonists or antagonists thereof, have a therapeutically useful role.

  本发明提供化合物及其药学上可接受的组合物，以及使用它们治疗一系列疾病或病症的方法，其中包括肝细胞生长因子/散发因子（HGF/SF）或其活性，或其激动剂或拮抗剂在治疗中具有治疗作用。
• Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
  申请人：Ansorge Siegfried

  公开号：US20070037752A1

  公开（公告）日：2007-02-15

  The invention relates to substances which specifically inhibit peptidases splitting ala-p-nitroanilide for use in medicine. The invention further relates to the use of at least one such substance or of a pharmaceutical or cosmetic composition containing at least one such substance for the prophylaxis and therapy of diseases, in particular the prophylaxis and therapy of diseases with an overshooting immune response (autoimmune diseases, allergies and transplant rejections), of other chronic inflammatory diseases, neuronal diseases and brain damages, skin diseases (acne and psoriasis, among others), tumor diseases and special virus infections (including SARS).
• [DE] NEUE ALANYL-AMINOPEPTIDASEN-INHIBITOREN ZUR FUNKTIONELLEN BEEINFLUSSUNG UNTERSCHIEDLICHER ZELLEN UND ZUR BEHANDLUNG IMMUNOLOGISCHER, ENTZÜNDLICHER, NEURONALER UND ANDERER ERKRANKUNGEN<br/>[EN] NOVEL ALANYL-AMINO PEPTIDASE INHIBITORS FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES<br/>[FR] NOUVEAUX INHIBITEURS D'ALANYL-AMINOPEPTIDASES DESTINES A EXERCER UNE INFLUENCE FONCTIONNELLE SUR DIVERSES CELLULES ET A CONSTITUER UN TRAITEMENT IMMUNOLOGIQUE DE MALADIES INFLAMMATOIRES, NEURONALES ET AUTRES
  申请人：INST MEDIZINTECHNOLOGIE MAGDEB

  公开号：WO2005037257A2

  公开（公告）日：2005-04-28

  Die vorliegende Erfindung betrifft Substanzen, die Ala-p-Nitroanilid spaltende Peptidasen spezifisch inhibieren, für die Verwendung in der Medizin. Weiter betrifft die Erfindung die Verwendung mindestens einer derartigen Substanz oder mindestens einer mindestens eine derartige Substanz enthaltenden pharmazeutischen oder kosmetischen Zusammensetzung zur Prophylaxe und Therapie von Erkrankungen, insbesondere zur Prophylaxe und Therapie von Erkrankungen mit überschiessender Immunantwort (Autoimmunerkrankungen, Allergien und Transplantatrejektionen), von anderen chronisch-entzündlichen Erkrankungen, neuronalen Erkrankungen und zerebralen Schädigungen, Hauterkrankungen (u. a. Akne und Schuppenflechte), Tumorerkrankungen und speziellen Virusinfektionen (u. a. SARS).
• [EN] SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY<br/>[FR] MODULATEURS À PETITES MOLÉCULES DE L'ACTIVITÉ DU FACTEUR DE CROISSANCE (FACTEUR DE DISPERSION) DES HÉPATOCYTES
  申请人：ANGION BIOMEDICA CORP

  公开号：WO2010068287A2

  公开（公告）日：2010-06-17

  The present invention provides compounds and pharmaceutically acceptable compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which hepatocyte growth factor/scatter factor (HGF/SF) or the activities thereof, or agonists or antagonists thereof, have a therapeutically useful role.